FAYETTEVILLE — A researcher at the University of Arkansas has received a patent for a drug intended to treat hair loss.
Associate chemistry and biochemistry professor Joshua Sakon is one of four co-inventors of the pharmaceutical protein now known as BMD-2341. The patent was issued June 23 to the UA board of trustees, the Ochsner Clinic Foundation and the National University Corporation Kagawa University in Japan.
BiologicsMD, a drug discovery firm based at the Arkansas Research and Technology Park, holds the exclusive license to the patented technology and is developing a line of protein therapeutics and drug-device combination products to treat hair loss and baldness.
Sakon said the drug has been successful in treating hair loss in mice. It now moves into clinical trials.